Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12424197 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Conditions: Hematologic Diseases;   Anemia, Sickle Cell;   Beta-Thalassemia;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Sangstat;   Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Mycophenolate Mofetil;   Drug: Cyclosporine;   Procedure: Cord Blood Transplantation

Indicates status has not been verified in more than two years